News & Events

Any conversation with Troy LeMaile-Stovall will always be punctuated by action words that lead to a more inclusive and productive environment.

As the Director of Federal Programs, Kim is responsible for engaging with the federal government to convert scientific research into new jobs and new businesses.

Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced it submitted an Investigational New Drug (IND) application with the U.S. Food and Drug

Maryland Technology Development Corp. (TEDCO) will distribute $5 million to local startups that have been hit especially hard by the Covid-19 pandemic, namely rural businesses or those led by socially and economically disadvantaged founders.